Dasatinib 100 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DR26FY8EA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,088
Award facts
- Contract value 100% obligated
- $19,087.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,087.93 to AmerisourceBergen Drug Corp for the supply of Dasatinib 100 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order was issued on November 13, 2025, with an ultimate completion date of November 14, 2025. The contract utilizes no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Dasatinib is a targeted cancer therapy medication commonly used in the treatment of chronic myeloid leukemia and acute lymphoblastic leukemia, reflecting the Defense Logistics Agency's procurement of specialized pharmaceutical products to support military and veteran healthcare systems.
This delivery order represents a task order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen maintains an extensive portfolio of medical product deliveries supporting military healthcare programs worldwide. The company's DLA contract vehicle enables supply of a comprehensive range of pharmaceutical products, brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FY8EA?
SPE2DR26FY8EA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26FY8EA worth?
The government has obligated $19,088 on SPE2DR26FY8EA.
Is contract SPE2DR26FY8EA an order under another contract?
Yes. SPE2DR26FY8EA is a delivery order under SPE2DR25D1007, an indefinite delivery contract.
Was contract SPE2DR26FY8EA competed?
The extent of competition for SPE2DR26FY8EA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award